Jeffrey S. Hackman Fennec Pharmaceuticals Inc. (FENC) insider trading activity

FENC Quotes by TradingView

Jeffrey S. Hackman is Chief Executive Officer of FENNEC PHARMACEUTICALS INC.. Currently has a direct ownership of 15,000 shares of FENC, which is worth approximately $114,000. The most recent transaction as insider was on May 19, 2025, when has been sold 13,965 shares (Common Shares) at a price of $6.99 per share, resulting in proceeds of $97,615. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15K
n/a 3M change
n/a 12M change
Total Value Held $114,000

Jeffrey S. Hackman Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 19 2025
BUY
Open market or private purchase
$97,615 $6.99 p/Share
13,965 Added 48.21%
15,000 Common Shares
May 16 2025
BUY
Open market or private purchase
$6,986 $6.75 p/Share
1,035 Added 50.0%
1,035 Common Shares

Also insider at

CMRA
Comera Life Sciences Holdings, Inc. Healthcare
Director
JSH

Jeffrey S. Hackman

Chief Executive Officer
Woburn, MA

Track Institutional and Insider Activities on FENC

Follow FENNEC PHARMACEUTICALS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FENC shares.

Notify only if

Insider Trading

Get notified when an Fennec Pharmaceuticals Inc. insider buys or sells FENC shares.

Notify only if

News

Receive news related to FENNEC PHARMACEUTICALS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FENC